Range Low Price High Price Comment
30 days $0.0511 $0.0700 Monday, 29th Apr 2024 BLPH stock ended at $0.0551. This is 0.542% less than the trading day before Friday, 26th Apr 2024. During the day the stock fluctuated 8.98% from a day low at $0.0551 to a day high of $0.0601.
90 days $0.0470 $0.0700
52 weeks $0.0290 $11.15

Historical Bellerophon Therapeutics prices

Date Open High Low Close Volume
Jul 20, 2020 $13.31 $13.55 $12.96 $13.46 133 000
Jul 17, 2020 $13.75 $14.00 $13.34 $13.44 95 500
Jul 16, 2020 $13.76 $14.00 $13.48 $13.79 168 200
Jul 15, 2020 $13.49 $14.09 $13.21 $13.68 347 500
Jul 14, 2020 $13.06 $13.61 $12.95 $13.57 154 300
Jul 13, 2020 $13.45 $14.04 $12.93 $13.06 288 800
Jul 10, 2020 $13.02 $13.26 $12.86 $12.97 105 900
Jul 09, 2020 $13.15 $13.23 $12.67 $13.02 196 000
Jul 08, 2020 $13.40 $13.57 $12.85 $12.98 148 600
Jul 07, 2020 $13.28 $13.91 $13.02 $13.38 146 700
Jul 06, 2020 $13.00 $13.60 $12.94 $13.45 255 400
Jul 02, 2020 $12.43 $13.16 $11.86 $12.96 188 982
Jul 01, 2020 $12.51 $12.86 $12.14 $12.18 134 528
Jun 30, 2020 $12.86 $13.01 $12.48 $12.55 106 104
Jun 29, 2020 $12.48 $13.11 $12.20 $12.96 224 120
Jun 26, 2020 $12.54 $13.23 $12.41 $12.80 700 567
Jun 25, 2020 $12.49 $12.76 $12.23 $12.58 245 087
Jun 24, 2020 $12.99 $13.07 $12.44 $12.56 250 576
Jun 23, 2020 $13.03 $13.24 $12.77 $13.20 168 174
Jun 22, 2020 $13.18 $13.38 $12.92 $13.00 135 635
Jun 19, 2020 $13.50 $13.74 $13.12 $13.28 305 716
Jun 18, 2020 $13.18 $13.51 $13.02 $13.49 160 553
Jun 17, 2020 $13.70 $13.89 $13.18 $13.37 180 499
Jun 16, 2020 $12.98 $13.93 $12.78 $13.84 327 647
Jun 15, 2020 $12.20 $13.45 $12.20 $12.92 188 497
Click to get the best stock tips daily for free!

About Bellerophon Therapeutics

Bellerophon Therapeutics Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated w... BLPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT